CELL SIGNALING TECHNOLOGY search Cell Signaling Technology FASLG products
includes other brands or spellings
|
| wb | | Cell Signaling Technology Fas ligand antibody was used in western blot to study apoptotic induction by apicidin in human Bcr-Abl-positive leukemia cells. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology FASLG products
includes other brands or spellings
|
| elisa | | Santa Cruz Biotechnology N20 goat and rabbit polyclonal anti-Fas ligand (FasL) antibodies were used in ELISA to study the solation and characterization of human nuclear and cytosolic multisynthetase complexes and the intracellular distribut. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal anti-FasL antibody was used in western blot to detect FasL in MCF-7 cells treated with 5-FU or RTX. |
| wb | | Santa Cruz Biotechnology polyclonal anti-FasL antibody was used in western blot to study the intracellular localization or functional domains of Par-4 involved in apoptosis. |
EMD BIOSCIENCES search EMD Biosciences FASLG products
includes other brands or spellings
|
| elisa | | Oncogene Research Products polyclonal anti-Fas ligand (FasL) antibody Ab-3 was used in ELISA to study the solation and characterization of human nuclear and cytosolic multisynthetase complexes and the intracellular distribution of p43/EMAPII. |
BD BIOSCIENCES search BD Biosciences FASLG products
includes other brands or spellings
|
| block, wb | | Pharmingen anti-hFasL antibodies Nok-1 and G-247 were used in activating expriments and western blot to study the binding of the intracellular Fas Ligand (FasL) domain to the adaptor protein PSTPIP which results in the cytoplasmic localization of FasL. |
| block | | Pharmingen mouse anti-Fas-L antibody (clone NOK-1) was used in U937 human monocytes and in blocking expriments to study the role for the antibody-activated macrophages in killing human mesangial cells. |
MEDICAL & BIOLOGIC LABORATORIES CO
|
| elisa | | Medical & Biologic Laboratories Co. CD95L sandwich ELISA kit was used to study TNF alpha -induced apoptosis of neonatal blood granulocytes. |
Articles Reviewed |
| 1. Nadia El-Guendy et al. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. 2003 |
| 2. June-Won Cheong et al. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. 2003 |
| 3. J Clifford Murray et al. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism. 2004 |
| 4. Daniel Broderick Longley et al. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. 2004 |
| 5. J J Boyle et al. Human macrophages kill human mesangial cells by Fas-L-induced apoptosis when triggered by antibody via CD16. 2004 |
| 6. Chieh-An Liu et al. Higher spontaneous and TNFalpha-induced apoptosis of neonatal blood granulocytes. 2005 |
| 7. Wiebke Baum et al. Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL. 2005 |